Supplementary Protection Certificate (SPC) Summary | |||
SPC No. | 2019/010 | ||
---|---|---|---|
Date of filing | 20/02/2019 | ||
Notification of Application Published | 20/03/2019 | ||
Status | Rejected | ||
Notification of Grant Published | |||
Date of Expiry of SPC | |||
Applicant |
ARRAY BIOPHARMA INC. 3200 Walnut Street Boulder Colorado 80301 UNITED STATES OF AMERICA |
||
Patent Number | 2727918 | ||
Title of Invention | Compounds and Compositions as Protein Kinase Inhibitors | ||
Date of Expiry of Patent | 26/08/2030 | ||
Product Type | Medicinal Product | ||
Product Identity | Combination of binimetinib and encorafenib, each in all forms protected by the basic patent | Market Authorisation | Ireland | European Union |
Authorisation No | EU/1/18/1315 | EU/1/18/1314 | |
Authorisation Date | 24/09/2018 | 24/09/2018 | |
Identity of Product Authorised | MEKTOVI(Binimetinib) | BRAFTOVI(encorafenib) | Market Authorisation | Ireland | European Union |
Authorisation No | EU/1/18/1314 | EU/1/18/1315 | |
Authorisation Date | 24/09/2018 | 24/09/2018 | |
Identity of Product Authorised | BRAFTOVI(encorafenib) | MEKTOVI(Binimetinib) | |
Address for Service |
HANNA MOORE + CURLEY Garryard House 25/26 Earlsfort Terrace Dublin 2 D02 PX51 IRELAND |
||
Renewal Fees | |||
01/03/2019 | Request for grant a Supplementary Protection Certificate filed on 20/02/2019, numbered 2019/010. | ||
28/01/2021 | Request for grant of Supplementary Protection Certification No. 2019/010 rejected in respect of Article 10(2) of Regulation (EC) No. 469/2009 | ||
24/03/2021 | Written grounds of decision issued on 12 March 2021. |